Technology transfer and scale-up of the Flublok® recombinant hemagglutinin (HA) influenza vaccine manufacturing process-Reference-Cited by-同舟云学术

Technology transfer and scale-up of the Flublok® recombinant hemagglutinin (HA) influenza vaccine manufacturing process

Published:2014-09 Issue:42 Volume:32 Page:5496-5502
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Buckland Barry^ORCID,Boulanger Robert,Fino Mireli,Srivastava Indresh,Holtz Kathy,Khramtsov Nikolai,McPherson Clifton,Meghrous Jamal,Kubera Paul,Cox Manon M.J.

Funder

Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference22 articles.

1. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis;Nair;Lancet,2011

2. Preliminary estimates of mortality and years of life lost associated with the 2009 A/H1N1 pandemic in the US and comparison with past influenza seasons;Viboud;PLoS Curr,2010

3. Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: a randomized, placebo-controlled.trial_2011;Treanor;Vaccine,2011

4. Vaccine process technology;Josefsberg;Biotechnol Bioeng,2012

5. Low 2012–13 influenza effectiveness associated with mutation in the egg adapted H3N2 vaccine strain not antigenic drift in circulating viruses;Skowronski;PLOS ONE,2014

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering immune responses: a comparative analysis of influenza vaccination platforms;Drug Discovery Today;2024-09

2. Innovations in cell culture-based influenza vaccine manufacturing – from static cultures to high cell density cultivations;Human Vaccines & Immunotherapeutics;2024-07-15

3. Vaccine process technology—A decade of progress;Biotechnology and Bioengineering;2024-05-06

4. Modeling scalability of impurity precipitation in downstream biomanufacturing;Biotechnology Progress;2024-03-27

5. Development of Stable Packaging and Producer Cell Lines for the Production of AAV Vectors;Microorganisms;2024-02-13